共 11 条
[1]
[Anonymous], 2011, COCHRANE HDB SYSTEMA
[2]
[Anonymous], 2012, METHODS GUIDE EFFECT
[3]
Higgins JPT., 2017, COCHRANE HDB SYSTEMA
[4]
Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2700, 10.1371/journal.pmed.1000097, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1016/j.ijsu.2010.07.299, 10.1136/bmj.b2535]
[5]
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration
[J].
COCHRANE DATABASE OF SYSTEMATIC REVIEWS,
2014, (09)
[7]
Olsen H, 1999, BLOOD PRESSURE, V8, P94
[9]
Schneeweiss S., 2012, Pharmacoepidemiology, P868, DOI DOI 10.1002/9781119959946.CH4
[10]
Singh JA, 2011, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD008794.PUB2

